1. Introduction {#s0005}
===============

Alterations in the arterial partial pressure of oxygen (O~2~) and carbon dioxide (CO~2~) lead to changes in cerebral blood flow and vasculature ([@bb0305]), and this response, when used in combination with a variety of imaging techniques, has been used to study brain physiology and disease for many years ([@bb0005], [@bb0030], [@bb0405]). Magnetic resonance imaging (MRI) is a safe, non-invasive, repeatable technique with high spatial resolution, which can provide detailed structural and functional information about the brain. In this paper, we define respiratory challenge MRI as the modification of arterial oxygen (PaO~2~) and/or carbon dioxide (PaCO~2~) concentration to induce a change in cerebral function or metabolism which is then measured by MRI. This approach has been used for some time for optimization and calibration of fMRI sequences ([@bb0250]), but there is increasing interest in the use of functional and/or perfusion MRI to examine brain pathophysiology. In particular, cerebral blood flow, oxygenation, metabolic rate and microvascular function in diseases such as stroke ([@bb0105]), dementia ([@bb0070]), epilepsy ([@bb0290]) and brain neoplasm ([@bb0260], [@bb0640]).

A number of approaches have been explored. These can range from simple modification of respiratory rate, including breath hold ([@bb0260]) and hyperventilation, to complex modelling of both respiratory parameters and brain signal change ([@bb0390], [@bb0505]). Whilst excellent articles reviewing the rationale and uses of these procedures are available (see Krainik for a recent review of functional imaging of brain perfusion ([@bb0325])), there are significant practical challenges in undertaking these methods. The aim of this review is to \[1\] review the rationale for respiratory challenge MRI in brain disease, \[2\] discuss techniques, equipment, monitoring and planning such experiments, and \[3\] propose some recommendations for optimization of these studies.

2. Rationale {#s0010}
============

The human brain employs an elegant system of regulation of cerebral blood flow (CBF) to ensure adequate delivery of O~2~ and nutrients to brain tissue, according to need and regardless of changes in blood pressure, oxygenation or other factors. CBF is determined by the following equation:$${CBF} = \frac{\mathit{Cerebral\ perfusion\ pressure}\ \left( \mathit{CPP} \right)}{\mathit{Cerebrovascular\ resistance}}.$$

Normal global CBF is around 50 mL/100 g/min ([@bb0310]) with higher values in grey compared to white matter ([@bb0350]) (see [Table 1](#t0005){ref-type="table"} for further definitions). However, CBF varies according to age, time of day, anatomical area and neuronal activity in order to maintain adequate nutrient delivery. The principle mechanism by which CBF is adjusted according to demand is by changing cerebrovascular resistance. This is governed by small cerebral vessels, particularly pre-capillary arterioles (\< 100 μm) ([@bb0610]), which are able to change calibre in response to a number of stimuli, a process known as cerebrovascular reactivity (CVR). Capillaries may also have an important role in vasoreactivity through the action of pericytes ([@bb0225]). If CVR is impaired, then increased CBF will not occur when required by brain activity.

Whilst a variety of methods exist for measuring CBF, there are difficulties in obtaining accurate, quantifiable CBF measurements, including interindividual variability ([@bb0350]), external factors ([@bb0340]), and inaccuracies in modelling methods ([@bb0150]). Large patient groups or large disease-related effects may be needed to detect differences in baseline CBF in disease states.

Measuring CVR, or the response of vessels, is an alternative technique. Vasoreactivity may be measured by applying a "challenge" such as modification of arterial gas concentration or the vasodilator acetazolamide ([@bb0575]). Acetazolamide is thought to work by causing inhibition of erythrocyte carbonic anhydrase resulting in impaired clearance of CO~2~ and acidosis which causes vascular smooth muscle relaxation. This causes an increase in CBF, without affecting CMRO~2~ ([@bb0595]). Usually administered with a standard dose of 1000 mg, it is safe and usually well tolerated, without changes in systemic parameters ([@bb0570]). There are a number of disadvantages including side effects such as paraesthesia and headaches, along with reports of reversible neurological deficts thought to be secondary to ischaemia ([@bb0315]). It has a number of drug interactions and must also be used with caution in subjects with hepatic or renal dysfunction or electrolyte disturbances, limiting its use in some patient groups ([@bb0150]). Its lack of reversibility means it can only be used once in an MRI session whereas modification of arterial gas concentration, or "respiratory challenge" is reversible and more versatile.

The use of a challenge uses the individual as their own control and negates some of the problems of direct measurement ([@bb0150]). CBF, and hence CVR, can be measured by MRI sequences including arterial spin labelling (ASL) or dynamic susceptibility contrast perfusion MRI ([@bb0620]).

Changes in vessel calibre in response to a challenge can lead to changes in other parameters such as oxygenation and cerebral blood volume, measurable by other MRI techniques (see below). Therefore the percentage change seen in respiratory challenge MRI is defined as:$$\%\text{change} = \frac{{\mathit{MRI}\ \mathit{parameter}}_{\mathit{postchallenge}} - {\mathit{MRI}\ \mathit{parameter}}_{\mathit{baseline}}}{{\mathit{MRI}\ \mathit{parameter}}_{\mathit{baseline}}} \times 100.$$

For standardization of signal change, it should be corrected for the change in gas concentration delivered to, or expired by, the subject. Therefore the general formula for defining CVR in respiratory challenge MRI is:$$\mathit{CVR} = \frac{\mathit{MRIparameter}_{\mathit{postchallenge}} - \mathit{MRIparameter}_{\mathit{baseline}}}{\mathit{MRIparameter}_{\mathit{baseline}}} \times \frac{100}{\left\lbrack \mathit{Gas} \right\rbrack_{\mathit{postchallenge}} - \left\lbrack \mathit{Gas} \right\rbrack_{\mathit{baseline}}}.$$

2.1. Gases {#s0015}
----------

O~2~ and CO~2~ have well described effects on cerebral vessel calibre and blood flow ([@bb0305]). Effects are rapid and reversible, with minimal side effects. Rapid initiation and cessation of a gas challenge allows repeated measurements during MRI (unlike acetazolamide, whose effects are long-lasting). Thus the ability to interrogate vasoreactivity by measuring vascular response to changes in O~2~ and CO~2~ may be useful to investigate cerebral pathophysiology.

### 2.1.1. The physiology of gas transport {#s0020}

Air, comprising 21% O~2~ and 0.04% CO~2~, is breathed in through the mouth and nose, and conducted to the lungs by the trachea and bronchi, which form anatomic dead space (i.e. they do not take part in gas exchange). Inspired air mixes with gas in the conducting airways. Within the alveoli, O~2~ diffuses into capillaries and is transported to the heart. Most O~2~ (\> 98%) is carried bound to haemoglobin within red blood cells, as oxyhaemoglobin, but the remaining amount is transported in arterial blood as a dissolved gas (referred to as the PaO~2~). The CaO~2~ is the total oxygen content of the arterial blood, including both dissolved and bound O~2~. It is calculated by the O~2~ content equation ([@bb0080]):$${CaO}_{2} = \left( {1.34 \times {Hb} \times \frac{\ {SaO}_{2}}{100}\ } \right) + \left( {0.023 \times {PaO}_{2}} \right)$$Where:

CaO~2~ = arterial oxygen content (mL/dL)

Hb = Haemoglobin (g/dL)

SaO~2~ = arterial oxygen saturation (%)

PaO~2~ = arterial partial pressure of oxygen (kPa).

Once arterial blood arrives in tissues, the acidic and hypercarbic environment along with reduced PaO~2~ causes O~2~ to be released from haemoglobin. Metabolizing tissues release CO~2~ which diffuses from capillaries into the venous circulation. CO~2~ is transported as either as a dissolved gas, bicarbonate (HCO~3~^--^~)~, or bound to proteins. In the lungs, CO~2~ diffuses into the alveoli, and is expired via the airways ([Fig. 1](#f0005){ref-type="fig"}A). End-tidal CO~2~ is the partial pressure of CO~2~ at the end of an exhaled breath. Normal EtCO~2~ is 4.0--5.7 kPa, and is 0.3--0.7 kPa lower than PaCO~2~ due to the mixture of gas in alveolar dead space. In normal healthy individuals, the difference is negligible but this becomes more marked in cardiac and pulmonary disease, as well as with increased age and smoking, due to increased dead space. This is also the case for differences in EtO~2~ and PaO~2~ ([@bb0035]).

### 2.1.2. Carbon dioxide {#s0025}

CO~2~ is one of the most important modulators of vascular tone, with increased CO~2~ (hypercapnia) leading to a relaxation of vascular smooth muscle and increased CBF. For each 1 mm Hg increase in PaCO~2~, CBF increases by 1--2 mL/100 g/min ([@bb0040], [@bb0305]). This relationship is characterized by an sigmoidal curve, with attenuated responses at the extremes ([@bb0455]) (See [Fig. 1](#f0005){ref-type="fig"}B). Resistance arterioles (40--100 μm) are more responsive to hypercapnia than larger arterioles (up to 400 μm), but responses to hypocapnia are independent of vessel size. Recent evidence has suggested that even major vessels, such as the middle cerebral artery, demonstrate diameter change in response to altered carbon dioxide ([@bb0100]). Cerebral blood volume (CBV) has a sigmoidal relationship to changes in PaCO~2~ ([@bb0205]).

CO~2~ is proposed to exert its effects after dissociating into the vasoactive agents H^+^ and HCO~3~. Increased H^+^ concentrations lead to activation of potassium channels and endothelial hyperpolarization ([@bb0015]) which is relayed to vascular smooth muscle cells. Intracellular calcium concentration reduces and vasorelaxation occurs ([@bb0140]). Alterations in CO~2~ have classically been thought not to lead to a change in metabolic O~2~ consumption ([@bb0305]) but more recent evidence suggests hypercapnia may lead to altered neuronal activity ([@bb0220]).

Rapid CO~2~ diffusion across alveoli allows CBF change within 6 s of a rise in CO~2~ with a CBF plateau being obtained within 45 s ([@bb0430]). However, the fall in CBF following restoration of normocapnia is much quicker ([@bb0430]). Adaptation to sustained hypercapnia does occur, with gradual restoration of normal CBF despite sustained hypercapnia. This occurs within hours, although others have argued this can occur within 10 min ([@bb0145]). This needs to be considered when designing respiratory challenge experiments.

Side effects such as nausea, flushing, hyperventilation, and transient neurological symptoms ([@bb0530]) may occur with hypercapnia along with anxiety, sensory stimulation and a panic like disorder ([@bb0095]). Hyperventilation induced by hypercapnia may increase motion artefacts ([@bb0545]). Ainslie and Duffin ([@bb0015]) recommended limiting delivery of FiCO~2~ to 8% for both subject safety and comfort. Despite side effects most subjects tolerate hypercapnia experiments. A review of 434 CVR MRI examinations using a rebreathing circuit and targeted EtCO~2~ of 50 mm Hg (6.7 kPa), reported transient symptoms in 11.1% of studies, no major complications, and successful CVR map generation in 83.9% of studies ([@bb0530]). Examined patients had a variety of diagnoses including atherosclerosis, Moyamoya vasculopathy, arteriovenous malformation, vasculitis and dissection.

Hypercapnia can increase systemic blood pressure (BP) ([@bb0305]), due to activation of the sympathetic nervous system, which may affect CVR measurements ([@bb0015], [@bb0240]). The vascular response to hypercapnia is lost when vessels are maximally dilated in response to low systemic BP (e.g. hypovolaemia), in an effort to maintain CBF ([@bb0205]). There is therefore a limit on the capacity to autoregulate. CVR to breath-hold and 6% CO~2~ breathing showed improved correlation when changes in blood flow velocity (measured by transcranial Doppler ultrasound) were corrected for changes in blood pressure, and therefore monitoring BP with compatible equipment during MRI experiments should be considered ([@bb0435]).

### 2.1.3. Oxygen {#s0030}

Within normal physiological values, changes in PaO~2~ have little effect on vessel radius or CBF (see [Fig. 1](#f0005){ref-type="fig"}) ([@bb0605]). Once PaO~2~ drops below 6.7 kPa, metabolic signals such as adenosine, along with the direct action of hypoxia on vascular smooth muscle, results in vasodilatation and increased CBF, allowing O~2~ delivery to remain constant ([@bb0195]). MRI experiments using hypoxia have been performed, usually in young healthy individuals ([@bb0400]). Hypoxic experiments require well controlled experimental conditions and may be inappropriate in patients.

The effects of hyperoxia are less clear but most studies have suggested it causes a reduction in CBF. In young healthy subjects blood flow, measured using phase-contrast MR angiography, decreased by up to 25% when a 100% oxygen was administered ([@bb0605]). Bulte and colleagues, using arterial spin labelling (ASL) MRI, proposed that CBF decreased even with minor hyperoxia, and continued to decline as FiO~2~ increased ([@bb0050]). Hyperoxia is proposed to have a direct vasoconstrictive effect on vessels via the attenuation of the effects of nitric oxide ([@bb0120]). This is more marked with hyperbaric O~2~ ([@bb0415]). However the effect of hyperoxia is complicated by two factors. Firstly hyperoxia leads to a small but significant reduction in EtCO~2~ probably due to increased tidal volume. Reduced EtCO~2~ leads to vasoconstriction, and this may be responsible for the change in CBF seen with hyperoxia. When changes in EtCO~2~ were corrected for in a phase-contrast MRI experiment, changes in FiO~2~ did not have a significant effect on CBF, suggesting CO~2~ is the predominant modulator of CBF ([@bb0635]). The second factor is that oxygen changes the MR relaxation properties of tissue and blood, which may have profound effects on measurements, particularly when using ASL. Adjustment for this may be required for the accurate quantification of CBF ([@bb0425]).

Studies using hyperoxia may therefore need to consider the measurement and control of CO~2~ and correct for changes in T1, which adds to the complexity of the experimental paradigm.

Hyperoxia can be used alone, or in combination with CO~2~ (carbogen) in respiratory challenge experiments. Carbogen increases both CBF and PaO~2~.

As well as affecting CBF, O~2~ has important effects on the BOLD signal in fMRI. With a FiO~2~ of 21% and normal atmospheric pressure, arterial haemoglobin (Hb) is almost completely saturated with O~2~ (creating diamagnetic oxyhaemoglobin). Elevated FiO~2~ increases the amount of gas dissolved in plasma in linear proportion to the partial pressure ([@bb0290]). This dissolved paramagnetic O~2~ alters the susceptibility between blood and tissue. It also has an effect via the oxygen-haemoglobin dissociation curve. Due to the increased PaO~2~ in the capillaries, there is a reduction in the dissociation of O~2~ from haemoglobin as the PaO~2~ does not fall sufficiently to allow its release. In conditions of hyperoxia therefore, the amount of deoxyhaemoglobin is nearly constant during capillary transit. This results in an increased T2\* signal and hyperoxic BOLD contrast ([@bb0485]).

Hyperoxia is associated with the release of oxygen free radicals, which may overwhelm endogenous antioxidant mechanisms, and lead to lipid peroxidation and plasma membrane breakdown particularly in the lungs ([@bb0285]). Reversible alveolar changes in human subjects after 17 h of over 95% oxygen suggested changes in alveolar-capillary barriers ([@bb0110]). Subjects may develop substernal pain, tracheobronchial irritation, tissue destruction and pulmonary oedema when FiO~2~ \> 50% is given for prolonged periods ([@bb0280], [@bb0375]). Hyperoxia may also lead to nitrogen washout and airway collapse ([@bb0135]). These effects occur only after several hours to days of prolonged hyperoxia, although they are enhanced by elevated atmospheric pressure ([@bb0280]). The duration of hyperoxia given within the context of an MR experiment are not thought to have any detrimental effects, but the "safety thresholds" for oxygen administration remain unclear.

3. Technique {#s0035}
============

3.1. preparation {#s0040}
----------------

Subjects with brain disease may have difficulties with informed consent and comprehension of protocols. Well planned exclusion criteria accompanied by thorough and early screening for any contraindications to MRI, may prevent subject drop out, avoid scanning delays and enhance data quality.

### 3.1.1. Exclusions {#s0045}

Normal MRI exclusion criteria should be followed ([@bb0295]). Subjects with claustrophobia or anxiety may struggle with MR scanning, and use of a face mask within the confines of the scanner bore may exacerbate this. Panic disorder patients may be hypersensitive to the anxiety inducing effects of CO~2~ ([@bb0095]). Patients with significant pulmonary or cardiac disease may need to be excluded from studies due to difficulties tolerating abnormal gas concentrations, issues with monitoring (see Monitoring below) and accurate measurement of end-tidal gases, and altered cerebral haemodynamics, such as in atrial fibrillation ([@bb0345], [@bb0420]).

#### 3.1.1.1. Oxygen {#s0050}

Patients requiring continuous O~2~ such as those with pneumonia (relevant in acute research such as stroke) may not tolerate periods of normoxia. Due to the potential risk of pulmonary atelectasis from hyperoxia, patients with bronchiectasis should be excluded. Subjects with type II respiratory failure have inadequate ventilation, causing a rise in resting PaCO~2~; hence the respiratory centre becomes driven by hypoxaemia. Hyperoxia can reduce ventilation leading to rises in PaCO~2~. Therefore patients with certain types of chronic obstructive pulmonary disease or respiratory muscle weakness (e.g. uncontrolled myasthenia gravis) should be excluded.

#### 3.1.1.2. Carbon dioxide {#s0055}

Subjects with known type II respiratory failure should not be subjected to hypercapnia in order to avoid further increase in PaCO~2~. Hyperventilation (to induce hypocapnia) should be avoided in those with a history of epilepsy as it may induce seizures ([@bb0210]). In subjects with unruptured intracranial aneurysms, conditions that cause alterations in the aneurysms transmural pressure gradient, such as hypertension or sudden alterations in intracranial pressure (ICP) secondary to hyperventilation, are proposed to increase the risk of rupture during aneurysm surgery ([@bb0090]). Therefore these subjects should be excluded.

3.2. Standardization of testing conditions {#s0060}
------------------------------------------

Factors that may influence blood flow and reactivity include time of day ([@bb0535]), nicotine ([@bb0520]), food ([@bb0565]), alcohol ([@bb0215]), body mass ([@bb0500]), haematocrit ([@bb0265]) and hormonal cycles ([@bb0025]). Visual stimulation and speaking will result in increased CBF to active brain regions ([@bb0275]), but sleep can reduce the cerebrovascular response to CO~2~ ([@bb0015]), so most tests may be best performed on an awake, silent patient with closed eyes. Numerous medications may influence cerebral haemodynamics including cholesterol-lowering drugs ([@bb0385]), angiotensin-receptor enzyme inhibitors ([@bb0600]), calcium channel blockers ([@bb0335]) and hormone replacement therapy ([@bb0410]), and patients may need to be excluded or medication withheld.

Caffeine reduces cerebral blood flow ([@bb0360]) and thus abstinence for a short period prior to a study may be advisable. However chronic caffeine use may lead to upregulation of vascular adenosine receptors to preserve CBF, and abstinence prior to a study could lead to a "withdrawal" rebound increase in CBF ([@bb0010]). As this is only likely to occur in patients with very high caffeine use (\> 600 mg/day or 4--7 cups of coffee) it has been suggested that these subjects should be excluded from perfusion studies ([@bb0010]) but the exact dosage of caffeine intake can be difficult to ascertain due to the variety of sources.

Temperature is known to influence cerebral blood flow ([@bb0330]). The temperature within the bore of a magnet may increase as scanning progresses due to radiofrequency energy ([@bb0615]). For studies using repeat imaging or prolonged scanning sessions, an increase in temperature could therefore potentially influence perfusion characteristics of the subject in the bore as there may be an increase in CMRO~2~ ([@bb0140]).

Standardised conditions developed for peripheral vascular function assessment are similarly applicable to cerebral perfusion studies, although may be difficult to implement in acute studies ([@bb0340], [@bb0580]). [Table 2](#t0010){ref-type="table"} reproduces some of these standards and includes others relevant to respiratory challenge MRI experiments.

3.3. A trial run {#s0065}
----------------

A trial run of the challenge outside the MRI with close monitoring including heart rate, blood pressure, respiratory rate and inspired and expired respiratory gas concentrations allows priming of the subject to the experience of the respiratory challenge in a less claustrophobic environment. Subjects have the opportunity to ask questions and report side effects. Safety concerns may also be identified prior to the MR experiment. Compliance and experimental success is likely to be increased ([@bb0545]). Local ethics committees may require trained medical personnel to be present but this is likely to vary according to protocol and patient group.

3.4. The respiratory challenge {#s0070}
------------------------------

The respiratory challenge should be easy to perform, tolerable, and give reliable gas concentrations. Unfortunately these ideal requirements are not always compatible, as highly accurate modifications in PaO~2~ and PaCO~2~ require a completely closed circuit and invasive monitoring i.e. an intubated and ventilated patient.

### 3.4.1. Ventilatory techniques {#s0075}

Ventilatory techniques, in their simplest form, do not require additional equipment, but do require patient compliance, limiting their use in cognitive impairment, sedation or confusion. Breath-holding causes hypercapnia and increased CBF, comparable to that achieved with 5% CO~2~ ([@bb0300], [@bb0445]). Breath hold may occur at the end of inspiration or expiration. End-expiration breath hold leads to an immediate rise in EtCO~2~, but the tolerable duration is shorter (due to hypoxia) and it may be more unpleasant for the patient thus increasing motion artefacts ([@bb0445]). Measurement of EtCO2 is also challenging during an end-expiration breath hold, with lower values and a confounding inspiration before the exhalation is measured. In comparison, end-inspiration breath hold is longer and more comfortable but changes in intrathoracic pressure result in a biphasic change in BOLD signal which needs to be factored into MRI measurements ([@bb0560], [@bb0550]). Both techniques are simple and practical for use in MRI. There are concerns about experimental repeatability due to variations in breath-hold duration ([@bb0560]), although as long as EtCO2 is measured repeatable measurements can be obtained ([@bb0045]). Additions to the technique include visual cueing, measurement of compliance with an abdominal pneumatic belt and paced breathing ([@bb0490], [@bb0555]), all of which add complexity and may reduce subject acceptability.

Respiratory tasks, including breath hold, and other conditions that result in a rise in hypercapnia, can cause confounding motion artefacts

Voluntary hyperventilation causes hypocapnia and reduced CBF ([@bb0440]). A period of \> 60 s can induce a fall of around 25% ([@bb0470]). Subjects are asked to modify their breathing rate and depth via visual cues, for a certain period or to a target EtCO~2~, which require training outside MRI ([@bb0590]). Hyperventilation may increase motion artefacts ([@bb0395]).

### 3.4.2. Fixed inspiratory challenge {#s0080}

Delivery of a fixed gas concentration via a non-rebreathing mask is passive and easy to perform. It requires a constant gas supply and a delivery method. Premixed gas cylinders can be used, or gas blenders may allow more variation in gas concentrations. 5% CO~2~ is proposed to raise CBF by 50% ([@bb0305]) and 100% O~2~ to reduce CBF by between 10% and 25% ([@bb0050]) ([@bb0605]). Fixed inspiratory challenge is effective for steady-state measures, such as ASL (62), or those with a block design, where a stimulus is given for set periods on several occasions in order to allow summation of results, usually with a continuous imaging method ([@bb0290]) ([Fig. 2](#f0010){ref-type="fig"}).

A fixed FiO~2~ or FiCO~2~ does not necessarily equate to a specific arterial concentration as this depends on ventilation, metabolic rate, age, lung function and the adequacy of the delivery circuit ([@bb0175]). Flow rates may depend on circuit design, including the use of reservoir bags. Circuits must be capable of supplying high enough flow rate to support the increased tidal volume seen with hypercapnia. An undershoot in EtCO~2~, may be seen following hypercapnia experiments as patients hyperventilate to expel excess CO~2~ ([@bb0630]).

Arterial concentrations may change even when the inspired concentration is kept constant e.g. increased ventilation in response to hypercapnia may lead to an elevated EtO2, which may influence MRI signal ([@bb0630]).

For these reasons, end-tidal gas concentrations should therefore be monitored to allow accurate signal quantification.

### 3.4.3. Rebreathing {#s0085}

Rebreathing of exhaled gas will result in equilibration of alveolar and arterial gases and a gradual increase in PaCO~2~. It is performed with a simple breathing circuit, with or without additional gases, and is generally well tolerated ([@bb0480]). However the speed and values of PaCO~2~ are not predictable and a plateau is difficult to achieve. Partial rebreathing circuits with fixed inspiratory challenges are proposed to achieve more stable EtCO~2~, but require significant patient cooperation ([@bb0585]). Rebreathing techniques allow the measurement of dynamic changes to a range of EtCO~2~ ([@bb0015]).

Rebreathing in a closed circuit will lead to a fall in delivered FiO~2~. Isooxia should be maintained for CVR measurement and to prevent the patient receiving a hypoxic gas mixture. Rebreathing methods where isooxia is achieved and ETCO~2~ is representative of PaCO~2~ have been described (for a recent review see [@bb0175])).

### 3.4.4. Dynamic end-tidal forcing {#s0090}

More precise control of EtCO~2~ and EtO~2~ has been advocated to permit more accurate adjustment of changes in MRI signal responses. Dynamic end-tidal forcing uses breath-by-breath computer control of inspired gas to achieve target EtCO~2~ and EtO~2~. This may increase repeatability both between subjects and sessions, and allows more complex variations of respiratory challenges to be performed ([@bb0630]). It is more expensive and complex to run than fixed inspiratory challenges, and breath-by-breath analysis can be hampered by the need for long gas sampling lines in MRI. It requires a high flow rate and there is the potential for the delivery of an anoxic mixture although this is avoided with use of the correct circuit ([@bb0630]). Issues with the accuracy of using EtCO~2~ to predict PaCO~2~ remain ([@bb0175]).

### 3.4.5. Prospective end-tidal targeting {#s0095}

Prospective end-tidal targeting has been a developed as a method to permit more accurate correlation of changes in EtCO~2~ with MRI signal responses ([@bb0270]). A tight-fitting mask is attached to a 3-valve circuit with inspiratory and expiratory reservoirs. Gas flow to the mask moves through a computer-controlled gas blender (Respiract; Thornhill Research, Toronto, Canada) which supplies O~2~, CO~2~ and nitrogen to achieve target EtCO~2~ and EtO~2~ independent of breathing pattern. Its advantages are that it allows rapid changes in gas concentration and that the end-tidal gases are equivalent to that of alveolar ventilation, and thus more accurately reflect tissue concentrations ([@bb0175]). A more detailed explanation of the method is available in [@bb0175]. It has been used to study cerebral physiology in a number of different disease states ([@bb0170], [@bb0245], [@bb0380]). This method in theory could allow the inclusion of patients with pulmonary disease as the EtCO~2~ will continue to accurately reflect PaCO~2~ ([@bb0270]), although the danger of exposure to hypercarbia or hyperoxia in these patients remains.

### 3.4.6. Motion artefacts {#s0100}

Respiratory challenges that result in hypercapnia or require the patient to make extreme ventilatory effort, such as breath hold, can result in motion artefacts which may result in a measured signal difference. This may confound the interpretation of results, particularly when a "baseline" versus "challenge" imaging design is used. It is important to ensure the patient is securely strapped into the head coil. Motion correction software or exclusion of patients with excessive head motion may also be needed([@bb0055]).

3.5. The environment and equipment {#s0105}
----------------------------------

Use of respiratory challenge adds complexities to the already difficult MR environment. As subject safety is paramount, all staff should undergo MRI safety induction training as per local guidelines ([@bb0160]).

### 3.5.1. Monitoring {#s0110}

Monitoring of gas concentrations is important for calculation of CVR, but may also be required for subject safety. Access to subjects is limited as the head is usually placed in a tight-fitting receiver coil (to enhance signal), padded and secured to limit movement. This complicates the delivery of gas, monitoring of subjects and verbal communication. Additional equipment must be MR safe or MR conditional and effective, and close liaison with anesthetists is recommended. Standard MR monitoring equipment must be correctly positioned to avoid the formation of inductive loops which may cause burns ([@bb0125]). ECG leads are prone to interference ([@bb0160]) and fibre optic MR connections preferred. Anaesthetic guidelines recommend that remote MR monitoring in the control room is available to reduce occupational exposure to magnetic fields and hearing damage ([@bb0160], [@bb0165]).

Whilst respiratory challenge MRI aims to modify cerebral tissue O~2~ and CO~2~, this is difficult to measure directly, and whilst arterial concentrations are representative they also require invasive monitoring. Non-invasive measurement of end-tidal gases is a more straightforward, if indirect measurement. Sampling should be performed as close to the subject\'s expired air flow as possible. The long sample lines necessitated by MRI will increase the time delay between sampling and recording (up to 20 s) ([@bb0160]). Secretions may block lines, and water traps dry out the sampled air, giving a dry value for expired gas. In normal atmospheric pressure a wet gas correction value of 0.94 can be applied to dry gas measurements ([@bb0035]). Capnography involves both the measurement and display of the EtCO~2~ value and waveform. It offers the advantage of assessment of circuit integrity (i.e. a reasonable seal) and allows identification of leaks or unplanned buildup of CO~2~.

There does however remain some question as to the accuracy of end-tidal measurements. Use of EtCO~2~ may only be appropriate with use of regression equations to adjust for changes in tidal volume, as ventilation will increase with a rise in delivered carbon dioxide ([@bb0015]). Use of prospective end-tidal targeting may offer advantages over unadjusted end-tidal gas readings ([@bb0270], [@bb0525]).

### 3.5.2. Gas delivery {#s0115}

#### 3.5.2.1. Nasal cannula {#s0120}

Nasal cannulas are simple, cheap and well tolerated, allowing unimpeded verbal communication. Tolerability is reduced with high flow rates as this can cause painful drying of the nasal mucosa. The main disadvantage is that patients can still mouth breath, although explanation may reduce this. It is possible to deliver 1--6 L/min of O~2~ (24--44%) and fixed concentrations of CO~2~ ([@bb0070]). There is greatly reduced control over inspired fractions, even with exclusive nasal breathing, as each patient entrails a different fraction of room air depending on their tidal volume. Normal nasal cannulas do not allow the monitoring of end-tidal gases but nasal cannulas with O~2~/CO~2~ combination monitoring are available. An alternative is the use of a mouth piece with nasal clip ([@bb0645]). However communication is hampered and patients may still be able to entrain room air from around the mouth piece.

#### 3.5.2.2. Face mask {#s0125}

Standard vented face masks are available which can deliver FiO~2~ up to 60% using 5-10L/min ([@bb0370]). Normal air can be breathed in through the vents, diluting the delivered gas concentrations. Most subjects will fit these masks and the seal can be improved by the use of tape. They are generally well tolerated but when used in a narrow head coil, they may be uncomfortable and result in subject drop out ([@bb0070]).

#### 3.5.2.3. Non-vented face mask {#s0130}

A non-rebreather mask or anaesthetic mask (non-vented), offers a much improved seal and reduced mask volume resulting in more controlled gas delivery and sampling. However the tight fit may make them less tolerable to patients and their structure is less malleable than standard face masks making them more difficult to fit into MRI head coils. Modified masks have been used to allow fit ([@bb0505]). As these masks are non-vented they create the risk of suffocation by rebreathing expired gas, and thus must be used with an appropriate breathing circuit such as a uni-directional valved circuit with a gas reservoir for safety ([@bb0505], [@bb0540]). These may improve the reliability of CBF experiments ([@bb0065]).

4. MRI sequences and examples of use in brain disease {#s0135}
=====================================================

4.1. BOLD signal: fMRI and SWI {#s0140}
------------------------------

Functional MRI using gradient-echo echo-planar imaging with strong T2\* weighting measures the blood-oxygenation level dependent (BOLD) signal. Oxyhaemoglobin is diamagnetic and has limited effect on T2\*-weighted signal. Deoxyhaemoglobin is paramagnetic and leads to a reduction in T2\*-weighted signal. The BOLD signal depends on CBF, CBV, cerebral metabolic rate of oxygen (CMRO~2~), haematocrit and PaO~2~,although in healthy subjects it is dominated by CBF ([@bb0510]).

Hypercapnia-induced CBF increase "washes out" deoxyhaemoglobin causing an increase in T2\* weighted signal ([@bb0510]). The signal difference between normocapnia and hypercapnia can be used to measure CVR. Validation studies using 15O PET have been used to compare BOLD signal change to relative CBF change in healthy volunteers([@bb0475]) In 25 patients with arterial steno-occlusive disease there was a strong correlation between hemispheric CVR using BOLD MRI and ASL MRI ([@bb0365]). In Moyamoya disease, CVR correlated with severity and the presence of collaterals ([@bb0245]). CVR mapping performed pre and post-operatively showed areas of vascular steal correlating with severe stenosis, which was resolved following successful revascularization, suggesting CVR mapping could be used for pre-operative planning ([@bb0380]) ([@bb0230]). CO~2~ challenge also demonstrated impaired CVR around arteriovenous malformations in those patients prone to seizures compared to those without a history of seizure ([@bb0170]).

In hyperoxic states, the extra dissolved O~2~ means oxygen remains bound to haemoglobin and results in a reduced concentration of deoxyhaemoglobin in tissues thereby increasing T2\* signal. We have investigated O~2~ challenge T2\*-weighted MRI in subjects with stroke within 24h of onset. The putative infarct core showed diminished T2\*-weighted signal increase compared to normal tissue, suggesting this technique may be able to tease out changes in metabolic activity ([@bb0105]). The technique has recently been validated in rodent models using T2\* oxygen challenge with measurements of CBF ([@bb0465]). O~2~ challenge T2\*-weighted MRI has also been investigated in temporal lobe epilepsy, with 7/10 patients showing changes in T2\* responses identifying seizure lateralization including two patients with normal MRI scans ([@bb0290]).

BOLD imaging allows the use of continuous measurements and assessment of dynamic responses to altered gas concentrations. In patients with Alzheimer\'s disease, maximal BOLD signal took longer to achieve than in normal controls suggesting some vasomotor impairment ([@bb0070]).

BOLD imaging with a respiratory challenge has therefore been used to: demonstrate physiological impairments such as reduced vascular reserve and vascular steal phenomenon; confirm disease laterality; correlate with clinical outcome measures; and to plan and predict surgical outcomes of revascularization.

Susceptibility-weighted imaging (SWI) is an alternative sequence sensitive to BOLD signal, and shows cerebral venous architecture and iron-containing tissues with high-spatial resolution. Expected BOLD responses to carbogen (95% O~2~, 5% CO~2~) and hyperoxia challenges have been detected in normal volunteers using SWI ([@bb0450]). Heterogeneous tumour response to carbogen and O~2~ was demonstrated in two patients with glioma, indicating tissue heterogeneity caused by necrotic, oedematous tissue and abnormal neovascularization ([@bb0450]). As tumour responsiveness to radiotherapy may be increased with increased tumour O~2~ levels ([@bb0200]), investigation of oxygenation and flow within brain tumours may aid disease management. SWI offers a way of imaging regional BOLD changes with high spatial resolution ([@bb0450]). However SWI is susceptible to motion artefacts which may be more likely to occur with higher FiCO~2~ ([@bb0495]).

CVR assessment may also be used to exclude patients with impaired CVR from fMRI studies, due to the risk of abolished BOLD responses in these patients ([@bb0320]).

4.2. Perfusion {#s0145}
--------------

Arterial spin labelling (ASL) imaging involves magnetically labelling protons in the arterial blood supply. As this blood passes into the brain, it causes a small signal loss in brain tissue compared to non-labelled images, which allows measurement of CBF. When used with a challenge, paired blood flow measurements, i.e. a baseline and then a stimulus, can be obtained allowing calculation of CVR. ASL offers the advantages of being non-invasive, repeatable, and quantifiable, but has the disadvantage of low signal-to-noise ratio in comparison to dynamic susceptibility weighted contrast methods for investigating perfusion ([@bb0620]). Arterial occlusion can lead to vessel-based artefacts in collateral circulation. These problems can be improved with high-field MRI and/or non-continuous ASL sequences.

ASL has been validated in conditions of rest, activity and hypercapnia challenge against ^15^O PET ([@bb0085]). Brain perfusion in dementia has been investigated using ASL and a 5% CO~2~ challenge in 49 patients. Regional CBF (rCBF) was lower and CVR impaired in frontal and temporal cortices of Alzheimer\'s disease patients, compared patients with in vascular dementia ([@bb0180]). Transcranial Doppler ultrasound (TCD) failed to demonstrate any difference in blood velocity or CVR. If regional patterns distinguish different types of dementia, this may offer an advantage over global measures of flow such as TCD. A rebreathing challenge was used to demonstrate an association between high cardiovascular risk profile and impaired hippocampal vasoreactivity in mild cognitive impairment ([@bb0190]), which was more sensitive than baseline CBF or brain volume. ASL performed with hypocapnic hyperventilation and CO~2~ rebreathing (95% O~2~, 5% CO~2~) challenges in 39 chronic large territory stroke patients, demonstrated reduced ipsilateral CBF but widespread impaired vasodilatory capacity with preserved vasoconstriction. This demonstrated that impaired vasoreactivity extends beyond the infarcted region. The continuous ASL technique has been shown to be quantifiable, although the long transit times seen in stroke may lead to underestimation of blood flow in stroke patients ([@bb0650]). This is because the flow is so slow, that the signal decays by the time it has reached the tissue being imaged.

Perfusion imaging with gadolinium bolus tracking is less commonly used in respiratory challenge experiments due to it being less easily repeated, requiring IV access, and gadolinium contrast having safety concerns in the face of extravasation or impaired renal function. MRI bolus tracking and acetazolamide challenge was used in 15 patients with CADASIL (cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy) to show impaired perfusion and reactivity in white matter hyperintensities ([@bb0075]) and we are currently undertaking both ASL and gadolinium bolus tracking with CO~2~ challenge in 22 CADASIL patients.

4.3. Dual echo imaging (BOLD and perfusion) {#s0150}
-------------------------------------------

BOLD and ASL can be used in sequence to provide information about the cerebrovascular system. Using both methods can permit the assessment of multiple measures of cerebral haemodynamics including CBF, CVR, BOLD CVR, oxygen extraction fraction and CMRO~2~([@bb0060], [@bb0185], [@bb0625]). In a study of patients with internal carotid artery occlusion, BOLD CVR signal was lower in the affected middle cerebral artery territory ([@bb0115]).

Vessel-specific labelling of blood, known as vessel encoded ASL (VE-ASL) has also been used in combination with BOLD in patients with cerebrovascular disease. BOLD signal change and CBF reactivity correlated significantly in response to carbogen, and was able to identify disease lateralisation in steno-occlusive carotid disease, although its application remains complex ([@bb0155]). The use of BOLD and carbogen results in an increase in BOLD signal both due to increased flow and increased partial pressure of oxygen, and therefore its use for calculation of CVR is complex and can lead to misleading results ([@bb0235]).

4.4. Cerebral blood volume: VASO {#s0155}
--------------------------------

Cerebral blood volume (CBV) has a linear relationship to changes in PaCO~2~ but a non-linear relationship to changes in CBF ([@bb0205]). The vascular space occupancy (VASO) technique is a CBV-weighted imaging technique which measures change in extravascular parenchymal signal. It has better spatial resolution than BOLD, but poor signal-to-noise ratio. It has been used to demonstrate signal decreases (suggesting increased intravascular blood volume) in grey matter in response to short periods of breath-hold in normal volunteers and patients with a meningioma ([@bb0255]). More negative VASO reactivity in response to breath-hold challenge was seen in patients with ICA stenosis compared to controls, proposed to represent haemodynamic impairment([@bb0130]). Using VASO with BOLD techniques may help extract the influence of CBV on the BOLD signal in disease states.

4.5. Other {#s0160}
----------

Other MRI sequences have also been used with respiratory challenge. Hyperventilation is known to provoke epileptiform activity, and was used to compare changes in diffusion (ADC) of temporal lobe epilepsy (TLE) patients with controls. TLE with hippocampal sclerosis patients showed higher baseline ADC in the abnormal hippocampus and a significant decrease in ADC compared to controls. Altered ADC at baseline is thought to represent altered cellular organization with the decrease in ADC with hyperventilation (and hypocapnia) caused by altered cellular permeability, cellular swelling and reduced extracellular space ([@bb0355]). Gadolinium-DTPA infusion with gradient-echo imaging, accompanied by T2\* weighted imaging, has been used to study contrast uptake in meningiomas. A hyperoxic hypercapnic challenge improved tumour oxygenation and increased contrast uptake rate in 6 out of 10 patients, who the authors proposed may be more responsive to radiotherapy with hyperoxygenation ([@bb0460]).

5. Recommendations {#s0165}
==================

Despite the variety of techniques available, application of respiratory challenge MRI may benefit from some standardization. Subject withdrawal may be reduced by ensuring the recruitment of subjects without MR or gas exclusions and undertaking a trial run of the procedure outside the MR scanner ([@bb0545]). Whilst centres will vary in the availability of equipment or expertise to use certain challenges or MR sequences, recording subject parameters and standardizing testing conditions may reduce testing variability and allow studies to be compared more readily. Some proposed recommendations for the conduct of respiratory challenge MRI studies are outlined in [Table 3](#t0015){ref-type="table"}.

6. Conclusions {#s0170}
==============

Respiratory challenge MRI has the potential to be widely used in the assessment of brain diseases due to its safety, tolerability and repeatability. Whilst problems remain with reliable gas administration, it has been used to provide valuable insights into brain pathophysiology. For such techniques to function as biomarkers to assess disease progression or treatment response, standardization of testing is important.
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![Transport of gases to the tissues and their effect on cerebral blood flow. (A) Oxygen (O~2~) is inspired into the alveoli and passes into the arterial blood for delivery to tissues. Carbon dioxide (CO~2~) produced by metabolizing cells is carried in the venous system and expelled through the lungs in expired gas. P~V~O~2~ and P~V~CO~2~ is the partial pressure of oxygen or carbon dioxide in venous blood. For other abbreviations see [Table 1](#t0005){ref-type="table"}. (B) Cerebral blood flow (CBF) in the normal physiological range of O~2~ is stable, but CBF increases in response to hypoxia and decreases in the presence of hyperoxia. Elevation of CO~2~ causes a linear increase in CBF except at the extremes, where vasoactive properties are exhausted, producing a sigmoid curve.](gr1){#f0005}

![Steady-state and dynamic respiratory challenges. (A) Arterial spin labelling (ASL) MRI performed whilst receiving air (left) and 6% CO~2~/air mixture (right) in a patient with cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL), demonstrating increased CBF in response to hypercapnia. Delivery of a 6% CO~2~ gas mixture caused a change in end-tidal CO~2~ (B) and separate scans were performed during each steady state. The red box represents the duration of the ASL scans. Continuous imaging can allow the application of repeated challenges and assess temporal resolution of signal in relation to gas concentrations. In (C) T2\* signal changes vary over an 11min fMRI in 4 normal volunteers given a dual hyperoxic challenge. Changes in end-tidal oxygen concentration for one patient receiving this challenge is shown in (D) and can be correlated with signal changes. The red box represents the duration of the scan.](gr2){#f0010}

###### 

Definitions and relevant normal values.

Table 1

  Parameter                            Abbreviation     Definition                                                                                                                                                                               Normal values
  ------------------------------------ ---------------- ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- --------------------------------------------
  Cerebral blood flow                  CBF              The volume of blood passing through the brain parenchyma in a defined time i.e. rate. This is usually defined in units of millilitres per 100 grams per minute.                          \~ 50 mL/100 g/min
  Cerebral blood volume                CBV              The fraction of a tissue volume occupied by blood                                                                                                                                        4--6 mL/100 g
  Cerebral metabolic rate for oxygen   CMRO~2~          The amount of oxygen consumed by 100 g of brain in 1 min.                                                                                                                                \~ 3.5 mL/100 g/min
  Cerebrovascular reactivity           CVR              Cerebral blood flow, or BOLD signal changes in response to stimuli usually measured as a percentage change in signal per change in CO~2~/O~2~                                            
  Arterial gas concentration           PaO~2~ PaCO~2~   Partial pressure of oxygen or carbon dioxide in arterial blood i.e. gas molecules dissolved in plasma.                                                                                   PaO~2~: 11--13 kPa PaCO~2~: 4.7--6 kPa
  End-tidal gas tension                EtO~2~ EtCO~2~   The partial pressure or maximum concentration of oxygen or carbon dioxide at the end of an exhaled breath.                                                                               EtO~2~: 16--17% EtCO~2~: 5% (4.6--5.6 kPa)
  Fraction of inspired gas             FiO~2~ FiCO~2~   The fraction or percentage of oxygen or carbon dioxide in the air that is breathed by the subject. Normal air has an FiO~2~ of 0.21                                                      FiO~2~: 0.21 (21%) FiCO~2~: 0.0004 (0.04%)
  Oxygen saturation                    SaO~2~           The percentage of haemoglobin molecules which are oxygenated in arterial blood.                                                                                                          95--100%
                                       SvO~2~                                                                                                                                                                                                    
  Oxygen content                       CaO~2~           The amount of oxygen in the blood and therefore available for tissues.                                                                                                                   20 mL O~2~/dL
  Cerebrovascular resistance                            The resistance to the passage of blood created by arterioles and capillaries.                                                                                                            
  Autoregulation                                        Cerebral vascular bed alters vascular resistance to maintain blood flow in the face of changes in systemic blood pressure to match metabolic needs.                                      
  Vascular steal                                        A stimulus results in the redistribution of blood flow from regions of exhausted cerebrovascular reactivity (maximally dilated vessels) to areas with preserved vasodilatory capacity.   

###### 

Standardization of confounding factors in vascular testing (adapted from ([@bb0580]).

Table 2

  Confounding factors           In practice
  ----------------------------- ---------------------------------------------------------------------------------------------------------------
  Room temperature              Document. Be aware of increase in temperature with prolonged scanning and plan experiments with this in mind.
  Time of day                   Similar time of day for repeated measurements.
  Smoking                       Avoid for 3 h prior
  Food                          Avoid for 3 h prior
  Caffeine                      Avoid for 3 h prior (and exclude those with very high intake).
  Alcohol                       Avoid for 10 h prior
  Menstrual cycle               Stage in cycle recorded Aim for similar stage in repeat measurements
  Height, weight                Record
  Visual stimulation Speaking   Ask patients not to speak and to keep their eyes shut during reactivity testing
  Haematocrit                   Record
  Medication                    Record Consider withholding/excluding vasoactive medication
  Sleeping                      Patient should not be allowed to sleep during the scan
  Cardiac rhythm                Consider if this may influence data

###### 

Proposed recommendations for conducting a respiratory challenge MRI experiment.

Table 3

  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Perform a trial run of the gas challenge with the subject outside the scanner to assess tolerability and optimize subject compliance.
  Standardize testing conditions by following published guidelines for performing vascular tests including those outlined in [Table 2](#t0010){ref-type="table"}.
  Record delivered and end-tidal gases, along with respiratory rate and heart rate to ensure patient safety and to allow correlation with signal change. These values can then be used for quantification of the change in MR parameter.
  If examining steady-state effects of hypercarbia or hyperoxia, allow sufficient time for steady-state to be obtained.
  Liaise with anesthetists and MR physics department to ensure breathing apparatus and monitoring equipment is safe and MR appropriate.
  Exclude patients with significant pulmonary or cardiac disease.
  Ensure the gas supply is sufficient to support increases in minute ventilation.
  Use a maximum FiCO~2~ of 8% to avoid subject discomfort unless specifically indicated ([@bb0015]).
  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
